Pacific Edge's revenue climbs, US future still uncertain

Pacific Edge's revenue climbs, US future still uncertain
Very strong revenue growth, but profit still some distance away (Image: Pacific Edge)
Ella Somers
A boom in Pacific Edge’s Cxbladder test sales boosted the firm’s operating revenue soar by 71%, with a helping hand from favourable exchange rates.Chief executive Peter Meintjes said the 2023 financial year had been a year of “enormous change and achievement” for the cancer diagnostic company.“Pacific Edge is geared for growth,” he told the NZX.Operating revenue for the twelve months to March 31 rose $19.6 million, up from $11.4m in the previous year while total revenue jumped 88% to $26.1m.The revenue climb...

More Markets

Mercury announces reshuffle at its top table
Finance

Mercury announces reshuffle at its top table

The two new members of the executive team are internal candidates.

Cuncannon: building a plaintiff side law firm
Markets

Cuncannon: building a plaintiff side law firm

The class action industry in New Zealand is somewhat underdeveloped.

Why Ebos is hunting SMEs
Markets

Why Ebos is hunting SMEs

What's next for Ebos after the end of that Chemist Warehouse contract.

Spark outlines more possible asset sales
Finance

Spark outlines more possible asset sales

The Spark board has a calculation to make about dividend reinvestment policy.